# OnCo record icaht-prolonged-cytopenia (protocol). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/protocols/icaht-prolonged-cytopenia/>
  a schema:MedicalGuideline ;
  onco:kind "protocol" ;
  schema:identifier "icaht-prolonged-cytopenia" ;
  schema:name "Prolonged low blood counts after CAR T-cell therapy (ICAHT): grading, work-up and treatment"@en ;
  schema:alternateName "ICAHT"@en, "immune effector cell-associated hematotoxicity"@en, "prolonged cytopenia after CAR T"@en, "post-CAR T neutropenia"@en, "CAR-HEMATOTOX"@en, "stem cell boost after CAR T"@en ;
  schema:description "Low blood counts are the commonest side effect of CAR T-cell therapy. Most recover within weeks, but in some people counts stay low for months, raising infection risk. Teams check counts often, give growth factor injections, transfusions and infection-preventing tablets, and look at the bone marrow if counts stay low after about a month. Some need their own stored stem cells."@en ;
  schema:url <https://onco.cc/protocols/icaht-prolonged-cytopenia/> ;
  schema:dateModified "2026-11-11"^^xsd:date ;
  onco:tag "protocol", "cell-therapy", "car-t" ;
  onco:related <https://onco.cc/protocols/car-t-infection-prevention/>, <https://onco.cc/protocols/crs-grading-and-management/>, <https://onco.cc/protocols/iec-hs-management/> ;
  onco:technologies <https://onco.cc/technologies/car-t/>, <https://onco.cc/technologies/rejuv-tx-prolonged-cytopenias/> ;
  onco:drugs <https://onco.cc/drugs/filgrastim/>, <https://onco.cc/drugs/eltrombopag/>, <https://onco.cc/drugs/romiplostim/> ;
  onco:institutions <https://onco.cc/institutions/eha/>, <https://onco.cc/institutions/sitc/> ;
  onco:terms <https://onco.cc/terms/cytopenias/>, <https://onco.cc/terms/lymphodepletion/> .